Beyond Nuclear Genetics Let's Think Differently About CNS Disease Targets
Nuclear genes with mutations remain the primary focus for selecting biological drug targets, but we have yet to see a drug come to market from a...
Nat Genet Biochim Biophys Acta Schubert Baldo Amy Ripka Research On Parkinson Disease National Human Genome Research Institute
Source: clinicalleader.com